The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and ...

Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, delivering top candidates in ...

To address these shortcomings, we introduce SymPcNSGA-Testing (Symbolic execution, Path clustering and NSGA-II Testing), a ...

After 30 months of fast-paced innovation in quantum algorithms, six research groups are hoping to hit paydirt. But there can be only one big winner—if there is a winner at all.

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and projected to reach US$ 1,081.9 million ...

The simulator takes into account forecasted demand in each region, transportation costs, and the operational capacity of each warehouse.

EZ-editor™ platform, large-scale cell resources, and standardised workflows support faster and more reliable knockout ...

Open-ended genetic algorithm approach achieves breakthrough results in precision and explainabilityReston, Va., March 16, 2026 (GLOBE NEWSWIRE) -- Noblis, a leading provider of science, technology, ...

Funding will expand the range of Dualase(R) genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /CNW/ - Specific Biologics Inc. ("Specific"), a ...

Funding will expand the range of Dualase(R) genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /PRNewswire/ - Specific Biologics Inc. ("Specific"), a ...

ClearStrand-ASD is the first and only biochemical screening test for autism spectrum disorder, intended to help health care providers rule out autism when it is a concern. Available by prescription in ...

In the past decade, intelligent technology has moved from niche applications to a central role in everyday life. From ...